Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Enhancement and Availability
N
Nice Insight
Apr 6, 2017
PTV-M11-16-AP-015
Formulation
Drug Discovery and Development
PA TV (video)
Edward Rudnic, CEO, Dispersol
Related Content
AI-Designed ADC
Closing the Loop Between AI Design and Clinical Translation
David Alvaro, Ph.D.; Peyton Greenside
Pharma's Almanac
PAO-11-26-CL-02
Nov 20, 2026
Diabetes Cell Tx
The Next Generation of Diabetes Cell Replacement Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-26-PA-09
Nov 18, 2026
PAMCPs
Post-Approval Change Management and the Promise of ICH Q12
Pharma's Almanac
PAO-11-26-PA-07
Nov 11, 2026
MASH
MASH Drug Development Enters a New Era
Pharma's Almanac
PAO-11-26-PA-06
Nov 9, 2026
Parasitic Diseases
Therapeutics and Vaccines for Parasitic Infections: A Quick Overview and Recent Advances
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-26-PA-05
Nov 6, 2026
Metabolic Disease
Precision Medicine in Metabolic Disease: Can We Predict Who Responds to Which Therapy?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-26-PA-04
Nov 5, 2026
Sustainability
How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?
Pharma's Almanac
PAO-10-26-RT-01
Oct 30, 2026
Distributor
Beyond Logistics: How Modern Chemical Distributors Accelerate Pharmaceutical Development
Daisy Huerta
Ingredients + Specialties from Univar Solutions
PAO-10-26-CL-06
Oct 26, 2026
Antibody Data
Does Antibody Development Have a Data Problem?
Sophie Lutter, Ph.D.
Lab Thread
PAO-10-26-CL-08
Oct 26, 2026
Cell Therapy
Overcoming Formulation and Fill/Finish Challenges for Cell Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-26-PA-15
Oct 26, 2026
ASDs
The Evolving Science of Amorphous Solid Dispersions
Pharma's Almanac
PAO-10-26-PA-13
Oct 20, 2026
OpenAI Funding
OpenAI Foundation: The Why and How of Its Life Science Research Funding Agenda
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-26-PA-12
Oct 19, 2026
Previous slide
Next slide